Condition

Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

AstraZeneca (1)

Collaborator

Intervention

olaparib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

relapsed ovarian cancer, brca mutation, platinum sensitivity

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity Trial in Canada, United States (OLAPARIB)

Completed

Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity

OLAPARIB

Anchorage, Alaska
+46 more

Mar 22, 2022